725 results Egbert Vroom Partner Amsterdam Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business. The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite. Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all? The Foreign Subsidies Regulation’s initial focus on China Although the text of the Foreign Subsidies Regulation is not aimed at specific countries, the European Commission’s initial enforcement actions appear to be targeting Chinese subsidies. Stibbe advises the SCHMID Group Stibbe, together with Gleiss Lutz, has advised the SCHMID Group on its business combination with Pegasus Digital Mobility Acquisition Corp. and listing on NASDAQ. Stibbe Capital Markets Seminar On Thursday 20 June 2024, Stibbe will host its annual Capital Markets Seminar. This year, the seminar will discuss “The case for Amsterdam listings – now and in the future”. E-book: 'Sustainable Finance in Europe' Stibbe lawyers Marieke Driessen, Loes van Dijk and Ingrid van der Klooster contributed to the book 'Sustainable Finance in Europe' which was recently published. Listing Act: Expanded exemptions for managers to trade during closed periods In October 2024, the European Council adopted the EU Listing Act, a legislative package that includes changes to the Market Abuse Regulation. We discuss the expanded exemptions to the prohibition of PDMRs carrying out transactions during a closed period. Third time lucky: Intel wins loyalty rebate battle at EU top court The European Court of Justice has upheld the annulment of Intel’s EUR 1.06 billion fine for abuse of dominance. The judgment provides guidance on how to assess the anti-competitiveness of loyalty rebates. If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug. Tekst & Commentaar Mededingingsrecht Roos Elemans en Jurriaan van Gent droegen bij aan de nieuwe uitgave van Tekst & Commentaar Mededingingsrecht. Mede dankzij deze bijdrage kunnen (mededingings-)juristen actief op het gebied van investeringstoetsingen nu gebruikmaken van dit naslagwerk. EU Listing Act enters into force 4 December 2024 The EU Listing Act, which includes updates to the Prospectus Regulation, Market Abuse Regulation, Markets in Financial Instruments Regulation, and to the Markets in Financial Instruments Directive, has been published on 14 November 2024. Van procederen kun je leren? Rechterlijke toetsing van concentratiezaken in Nederland Roos Elemans en Simone Evans staan in een artikel voor het Tijdschrift Mededingingsrecht in de Praktijk stil bij de vraag: wel of geen beroep instellen tegen een concentratiebesluit? De Europese Commissie, de Staat en de (inter)nationale rechter: een staatssteunrechtelijk 'Game of Thrones' of checks and balances? De staatssteunrechtelijke bevoegdhedenverdeling tussen de Europese Commissie, de Staat en de rechter houdt de gemoederen bezig. Een voorbeeld hiervan biedt de Micula rechtspraak over investeringsarbitrage. Deze blog bespreekt dergelijke zaken. Stibbe Amsterdam appoints three new partners We are pleased to announce that Stibbe Amsterdam has promoted Roos Elemans, Lotte Hover-Boon and Daisy Nijkamp to partner effective 1 January 2025. These appointments will further strengthen our EU and Competition Law, Tax and Litigation practices. EU lift cartel damage claim rejected by Brussels Court of Appeal After 16 years of court battle, the Brussels Court of Appeal has rejected the EU’s EUR 12 million (+ interest) damage claim against the four lift producers that participated in the lift cartel fined in 2007. Stibbe represents Mercedes-Benz in class action concerning NOx emissions from diesel vehicles Stibbe is acting as defence counsel for Mercedes-Benz in mass litigation over allegations that the company installed prohibited defeat devices in its diesel-powered vehicles. Pagination Previous page Page 14 Current page 15 Page 16 Page 17 Next page
Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business.
The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite.
Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all?
The Foreign Subsidies Regulation’s initial focus on China Although the text of the Foreign Subsidies Regulation is not aimed at specific countries, the European Commission’s initial enforcement actions appear to be targeting Chinese subsidies.
Stibbe advises the SCHMID Group Stibbe, together with Gleiss Lutz, has advised the SCHMID Group on its business combination with Pegasus Digital Mobility Acquisition Corp. and listing on NASDAQ.
Stibbe Capital Markets Seminar On Thursday 20 June 2024, Stibbe will host its annual Capital Markets Seminar. This year, the seminar will discuss “The case for Amsterdam listings – now and in the future”.
E-book: 'Sustainable Finance in Europe' Stibbe lawyers Marieke Driessen, Loes van Dijk and Ingrid van der Klooster contributed to the book 'Sustainable Finance in Europe' which was recently published.
Listing Act: Expanded exemptions for managers to trade during closed periods In October 2024, the European Council adopted the EU Listing Act, a legislative package that includes changes to the Market Abuse Regulation. We discuss the expanded exemptions to the prohibition of PDMRs carrying out transactions during a closed period.
Third time lucky: Intel wins loyalty rebate battle at EU top court The European Court of Justice has upheld the annulment of Intel’s EUR 1.06 billion fine for abuse of dominance. The judgment provides guidance on how to assess the anti-competitiveness of loyalty rebates.
If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug.
Tekst & Commentaar Mededingingsrecht Roos Elemans en Jurriaan van Gent droegen bij aan de nieuwe uitgave van Tekst & Commentaar Mededingingsrecht. Mede dankzij deze bijdrage kunnen (mededingings-)juristen actief op het gebied van investeringstoetsingen nu gebruikmaken van dit naslagwerk.
EU Listing Act enters into force 4 December 2024 The EU Listing Act, which includes updates to the Prospectus Regulation, Market Abuse Regulation, Markets in Financial Instruments Regulation, and to the Markets in Financial Instruments Directive, has been published on 14 November 2024.
Van procederen kun je leren? Rechterlijke toetsing van concentratiezaken in Nederland Roos Elemans en Simone Evans staan in een artikel voor het Tijdschrift Mededingingsrecht in de Praktijk stil bij de vraag: wel of geen beroep instellen tegen een concentratiebesluit?
De Europese Commissie, de Staat en de (inter)nationale rechter: een staatssteunrechtelijk 'Game of Thrones' of checks and balances? De staatssteunrechtelijke bevoegdhedenverdeling tussen de Europese Commissie, de Staat en de rechter houdt de gemoederen bezig. Een voorbeeld hiervan biedt de Micula rechtspraak over investeringsarbitrage. Deze blog bespreekt dergelijke zaken.
Stibbe Amsterdam appoints three new partners We are pleased to announce that Stibbe Amsterdam has promoted Roos Elemans, Lotte Hover-Boon and Daisy Nijkamp to partner effective 1 January 2025. These appointments will further strengthen our EU and Competition Law, Tax and Litigation practices.
EU lift cartel damage claim rejected by Brussels Court of Appeal After 16 years of court battle, the Brussels Court of Appeal has rejected the EU’s EUR 12 million (+ interest) damage claim against the four lift producers that participated in the lift cartel fined in 2007.
Stibbe represents Mercedes-Benz in class action concerning NOx emissions from diesel vehicles Stibbe is acting as defence counsel for Mercedes-Benz in mass litigation over allegations that the company installed prohibited defeat devices in its diesel-powered vehicles.